ANI Pharmaceuticals Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$266,044	$237,462	$247,060	$227,813
Gross Profit	165,886	122,961	237,560	111,792
EBITDA	60,373	57,371	76,931	61,159
EBIT	40,733	36,452	54,318	38,527
Net Income	24,711	29,492	27,490	24,134
Net Change In Cash	266,044	237,462	247,060	227,813
Free Cash Flow	67,993	47,051	6,507	37,892
Cash	360,212	311,176	285,585	262,610
Basic Shares	21,915	21,544	21,228	21,093

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$883,366	$614,376	$486,816	$316,385
Gross Profit	450,639	364,166	305,303	177,600
EBITDA	207,268	63,121	106,603	25,040
EBIT	115,851	-4,610	46,812	-34,613
Net Income	78,337	-18,522	18,779	-47,896
Net Change In Cash	883,366	614,376	486,816	316,385
Cost of Revenue				-52,067
Free Cash Flow	150,904	47,064	100,448	-47,658
Cash	285,585	144,861	221,121	48,228
Basic Shares	21,228	19,318	18,194	16,260